Sara Nageeb Elhelaly Public Policy & Regulatory Affairs Senior Manager, US Pharmacopeia (USP) EMEA - Dr
J Nutr Biochem 17:7388 Cahova M, Chrastina P, Hansikova H, Drahota Z, Trnovska J, Skop V, Spacilova J, Malinska H, Oliyarnyk O, Papackova Z, Palenickova E, Kazdova L (2015) Carnitine supplementation alleviates lipid metabolism derangements and protects against oxidative stress in non-obese hereditary hypertriglyceridemic rats
In separate studies, somnolence was reported in 16% to 25% of patients receiving immediate-release tablets (incidence increasing with time up to 90 days), 7.3% to 20.3% of patients receiving extended-release coated tablets, 5% to 7% of those receiving dual-matrix extended-release tablets, and 11.7% to 16.1% of patients receiving extended-release capsules
If unpleasant effects arise, it is advisable to review dose, timing and rule out interactions, especially if medication is being taken
What the research shows Studies examining GHK-Cu use over periods of 2-3 months consistently show favorable safety profiles
LifeMD will work with your insurance provider, at no additional cost, to determine your coverage for prescription GLP-1 medication and initiate the prior authorization process for you, if needed